nodes	percent_of_prediction	percent_of_DWPC	metapath
Alogliptin—CYP3A4—Calcitriol—osteoporosis	0.125	0.158	CbGbCtD
Alogliptin—CYP3A4—Estropipate—osteoporosis	0.125	0.158	CbGbCtD
Alogliptin—CYP2D6—Cholecalciferol—osteoporosis	0.102	0.128	CbGbCtD
Alogliptin—CYP3A4—Ergocalciferol—osteoporosis	0.1	0.126	CbGbCtD
Alogliptin—CYP3A4—Raloxifene—osteoporosis	0.0837	0.105	CbGbCtD
Alogliptin—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0808	0.102	CbGbCtD
Alogliptin—CYP3A4—Cholecalciferol—osteoporosis	0.0646	0.0814	CbGbCtD
Alogliptin—CYP3A4—Conjugated Estrogens—osteoporosis	0.0593	0.0748	CbGbCtD
Alogliptin—CYP3A4—Estradiol—osteoporosis	0.0521	0.0657	CbGbCtD
Alogliptin—Diabetes mellitus—Raloxifene—osteoporosis	0.0054	0.0261	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Etidronic acid—osteoporosis	0.00428	0.0207	CcSEcCtD
Alogliptin—Nasopharyngitis—Ibandronate—osteoporosis	0.00416	0.0201	CcSEcCtD
Alogliptin—Pancreatitis—Estropipate—osteoporosis	0.00411	0.0199	CcSEcCtD
Alogliptin—Nasopharyngitis—Calcitriol—osteoporosis	0.00407	0.0197	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Estropipate—osteoporosis	0.0039	0.0188	CcSEcCtD
Alogliptin—Pancreatitis—Calcitriol—osteoporosis	0.00386	0.0187	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Ibandronate—osteoporosis	0.00374	0.0181	CcSEcCtD
Alogliptin—Erythema multiforme—Etidronic acid—osteoporosis	0.00367	0.0177	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Alendronate—osteoporosis	0.00365	0.0177	CcSEcCtD
Alogliptin—Nasopharyngitis—Risedronate—osteoporosis	0.00343	0.0166	CcSEcCtD
Alogliptin—Nasopharyngitis—Pamidronate—osteoporosis	0.00326	0.0158	CcSEcCtD
Alogliptin—Erythema multiforme—Estropipate—osteoporosis	0.00317	0.0153	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Ethinyl Estradiol—osteoporosis	0.00316	0.0153	CcSEcCtD
Alogliptin—Erythema multiforme—Alendronate—osteoporosis	0.00312	0.0151	CcSEcCtD
Alogliptin—Hypersensitivity—Calcium Acetate—osteoporosis	0.00309	0.015	CcSEcCtD
Alogliptin—Angioedema—Etidronic acid—osteoporosis	0.00309	0.0149	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Risedronate—osteoporosis	0.00308	0.0149	CcSEcCtD
Alogliptin—Erythema multiforme—Calcitriol—osteoporosis	0.00298	0.0144	CcSEcCtD
Alogliptin—Nasopharyngitis—Zoledronate—osteoporosis	0.00298	0.0144	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Pamidronate—osteoporosis	0.00293	0.0142	CcSEcCtD
Alogliptin—Pancreatitis—Conjugated Estrogens—osteoporosis	0.00272	0.0131	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Zoledronate—osteoporosis	0.00267	0.0129	CcSEcCtD
Alogliptin—Angioedema—Estropipate—osteoporosis	0.00267	0.0129	CcSEcCtD
Alogliptin—Angioedema—Alendronate—osteoporosis	0.00263	0.0127	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Conjugated Estrogens—osteoporosis	0.00257	0.0125	CcSEcCtD
Alogliptin—Erythema multiforme—Ethinyl Estradiol—osteoporosis	0.00257	0.0124	CcSEcCtD
Alogliptin—Angioedema—Ibandronate—osteoporosis	0.00256	0.0124	CcSEcCtD
Alogliptin—Anaphylactic shock—Estropipate—osteoporosis	0.00238	0.0115	CcSEcCtD
Alogliptin—Nasopharyngitis—Estradiol—osteoporosis	0.00229	0.0111	CcSEcCtD
Alogliptin—Anaphylactic shock—Ibandronate—osteoporosis	0.00229	0.0111	CcSEcCtD
Alogliptin—Anaphylactic shock—Calcitriol—osteoporosis	0.00224	0.0108	CcSEcCtD
Alogliptin—Urticaria—Etidronic acid—osteoporosis	0.00219	0.0106	CcSEcCtD
Alogliptin—Pancreatitis—Estradiol—osteoporosis	0.00217	0.0105	CcSEcCtD
Alogliptin—Angioedema—Ethinyl Estradiol—osteoporosis	0.00216	0.0105	CcSEcCtD
Alogliptin—Angioedema—Risedronate—osteoporosis	0.00211	0.0102	CcSEcCtD
Alogliptin—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.0021	0.0101	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Estradiol—osteoporosis	0.00206	0.00997	CcSEcCtD
Alogliptin—Hypersensitivity—Etidronic acid—osteoporosis	0.00203	0.00982	CcSEcCtD
Alogliptin—Angioedema—Pamidronate—osteoporosis	0.00201	0.0097	CcSEcCtD
Alogliptin—Urticaria—Estropipate—osteoporosis	0.00189	0.00916	CcSEcCtD
Alogliptin—Urticaria—Alendronate—osteoporosis	0.00187	0.00902	CcSEcCtD
Alogliptin—Angioedema—Zoledronate—osteoporosis	0.00183	0.00886	CcSEcCtD
Alogliptin—Urticaria—Ibandronate—osteoporosis	0.00182	0.00879	CcSEcCtD
Alogliptin—Anaphylactic shock—Pamidronate—osteoporosis	0.00179	0.00866	CcSEcCtD
Alogliptin—Urticaria—Calcitriol—osteoporosis	0.00178	0.0086	CcSEcCtD
Alogliptin—Angioedema—Conjugated Estrogens—osteoporosis	0.00176	0.00853	CcSEcCtD
Alogliptin—Hypersensitivity—Estropipate—osteoporosis	0.00176	0.0085	CcSEcCtD
Alogliptin—Rash—Etidronic acid—osteoporosis	0.00174	0.00841	CcSEcCtD
Alogliptin—Dermatitis—Etidronic acid—osteoporosis	0.00174	0.0084	CcSEcCtD
Alogliptin—Hypersensitivity—Alendronate—osteoporosis	0.00173	0.00837	CcSEcCtD
Alogliptin—Headache—Etidronic acid—osteoporosis	0.00173	0.00835	CcSEcCtD
Alogliptin—Hypersensitivity—Ibandronate—osteoporosis	0.00168	0.00815	CcSEcCtD
Alogliptin—Erythema multiforme—Estradiol—osteoporosis	0.00168	0.00812	CcSEcCtD
Alogliptin—Hypersensitivity—Calcitriol—osteoporosis	0.00165	0.00798	CcSEcCtD
Alogliptin—Anaphylactic shock—Zoledronate—osteoporosis	0.00164	0.00791	CcSEcCtD
Alogliptin—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00158	0.00762	CcSEcCtD
Alogliptin—Urticaria—Ethinyl Estradiol—osteoporosis	0.00154	0.00743	CcSEcCtD
Alogliptin—Rash—Estropipate—osteoporosis	0.0015	0.00727	CcSEcCtD
Alogliptin—Dermatitis—Estropipate—osteoporosis	0.0015	0.00727	CcSEcCtD
Alogliptin—Urticaria—Risedronate—osteoporosis	0.0015	0.00724	CcSEcCtD
Alogliptin—Headache—Estropipate—osteoporosis	0.00149	0.00723	CcSEcCtD
Alogliptin—Rash—Alendronate—osteoporosis	0.00148	0.00716	CcSEcCtD
Alogliptin—Dermatitis—Alendronate—osteoporosis	0.00148	0.00716	CcSEcCtD
Alogliptin—Headache—Alendronate—osteoporosis	0.00147	0.00712	CcSEcCtD
Alogliptin—Rash—Raloxifene—osteoporosis	0.00146	0.00704	CcSEcCtD
Alogliptin—Dermatitis—Raloxifene—osteoporosis	0.00145	0.00704	CcSEcCtD
Alogliptin—Headache—Raloxifene—osteoporosis	0.00145	0.007	CcSEcCtD
Alogliptin—Rash—Ibandronate—osteoporosis	0.00144	0.00697	CcSEcCtD
Alogliptin—Dermatitis—Ibandronate—osteoporosis	0.00144	0.00697	CcSEcCtD
Alogliptin—Headache—Ibandronate—osteoporosis	0.00143	0.00693	CcSEcCtD
Alogliptin—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00142	0.00689	CcSEcCtD
Alogliptin—Angioedema—Estradiol—osteoporosis	0.00141	0.00683	CcSEcCtD
Alogliptin—Rash—Calcitriol—osteoporosis	0.00141	0.00683	CcSEcCtD
Alogliptin—Dermatitis—Calcitriol—osteoporosis	0.00141	0.00682	CcSEcCtD
Alogliptin—Headache—Calcitriol—osteoporosis	0.0014	0.00678	CcSEcCtD
Alogliptin—Hypersensitivity—Risedronate—osteoporosis	0.00139	0.00672	CcSEcCtD
Alogliptin—Hypersensitivity—Pamidronate—osteoporosis	0.00132	0.00638	CcSEcCtD
Alogliptin—Urticaria—Zoledronate—osteoporosis	0.0013	0.00629	CcSEcCtD
Alogliptin—Anaphylactic shock—Estradiol—osteoporosis	0.00126	0.0061	CcSEcCtD
Alogliptin—Urticaria—Conjugated Estrogens—osteoporosis	0.00125	0.00605	CcSEcCtD
Alogliptin—Rash—Ethinyl Estradiol—osteoporosis	0.00122	0.00589	CcSEcCtD
Alogliptin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00122	0.00589	CcSEcCtD
Alogliptin—Headache—Ethinyl Estradiol—osteoporosis	0.00121	0.00586	CcSEcCtD
Alogliptin—Hypersensitivity—Zoledronate—osteoporosis	0.00121	0.00583	CcSEcCtD
Alogliptin—Rash—Risedronate—osteoporosis	0.00119	0.00575	CcSEcCtD
Alogliptin—Dermatitis—Risedronate—osteoporosis	0.00119	0.00574	CcSEcCtD
Alogliptin—Headache—Risedronate—osteoporosis	0.00118	0.00571	CcSEcCtD
Alogliptin—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00116	0.00561	CcSEcCtD
Alogliptin—Rash—Pamidronate—osteoporosis	0.00113	0.00546	CcSEcCtD
Alogliptin—Dermatitis—Pamidronate—osteoporosis	0.00113	0.00546	CcSEcCtD
Alogliptin—Headache—Pamidronate—osteoporosis	0.00112	0.00543	CcSEcCtD
Alogliptin—Rash—Zoledronate—osteoporosis	0.00103	0.00499	CcSEcCtD
Alogliptin—Dermatitis—Zoledronate—osteoporosis	0.00103	0.00499	CcSEcCtD
Alogliptin—Headache—Zoledronate—osteoporosis	0.00102	0.00496	CcSEcCtD
Alogliptin—Urticaria—Estradiol—osteoporosis	0.001	0.00485	CcSEcCtD
Alogliptin—Rash—Conjugated Estrogens—osteoporosis	0.000993	0.00481	CcSEcCtD
Alogliptin—Dermatitis—Conjugated Estrogens—osteoporosis	0.000992	0.0048	CcSEcCtD
Alogliptin—Headache—Conjugated Estrogens—osteoporosis	0.000987	0.00477	CcSEcCtD
Alogliptin—Hypersensitivity—Estradiol—osteoporosis	0.000929	0.00449	CcSEcCtD
Alogliptin—Rash—Estradiol—osteoporosis	0.000795	0.00385	CcSEcCtD
Alogliptin—Dermatitis—Estradiol—osteoporosis	0.000794	0.00384	CcSEcCtD
Alogliptin—Headache—Estradiol—osteoporosis	0.00079	0.00382	CcSEcCtD
